| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 1,948 | 863 | ||
| Prepaid expenses | 3,100 | 7,300 | ||
| Total current assets | 5,048 | 8,163 | ||
| Total assets | 5,048 | 8,163 | ||
| Accounts payable | 47,847 | 55,204 | ||
| Accounts payable related party-Related Party | 477 | 86,160 | ||
| Note payable | 100,000 | 100,000 | ||
| Notes payable related parties | 100,000 | - | ||
| Accrued expenses | 15,384 | 13,493 | ||
| Total current liabilities | 263,708 | 254,857 | ||
| Long-term liabilities | - | 0 | ||
| Total liabilities | 263,708 | 254,857 | ||
| Common stock 0.001 par value 90,000,000 authorized 83,548,469 and 83,548,469 shares issued and outstanding, as of september 30, 2025 and december 31, 2024, respectively | 83,549 | 83,549 | ||
| Additional paid-in capital | 9,594,687 | 9,594,687 | ||
| Accumulated deficit | -9,936,896 | -9,924,930 | ||
| Total stockholders' deficit | -258,660 | -246,694 | ||
| Total liabilities and stockholders' deficit | 5,048 | 8,163 | ||
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)